Brain Cancer
Early Trial Responses
A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.
The company has previously offered its liquid biopsy tests through an LDT model but sees the timing and the clinical niche as right for a regulatory bid in CSF testing.
Datar Cancer Genetics Obtains CE Mark for Liquid Biopsy Cancer Test
The firm said its test can be used to evaluate blood samples from people who present with suspicious growths in the breast, lung, prostate, colon, or brain.
Glioblastoma Omics Study Highlights Informative Tumor Features, Immune Subtypes
Genomic, transcriptomic, proteomic, and post-transcriptional modification features in nearly 100 GBM tumors offered clues to tumor biology, revealing four immune subtypes.
Glioblastoma Transcriptomes Point to Mitochondrial Subtype, Potential Treatment Strategies
Using single-cell and bulk RNA sequence data, investigators identified four pathway-based GBM subtypes, including a mitochondrial subtype that appears to respond to related inhibitors.